Brief: Veracyte’S Decipher Prostate Test Is Now The Only Gene Expression Test Recommended In Nccn® Prostate Cancer Guidelines
05/12/2024 21:36
Dec 5 (Reuters) - Canadian National Railway Co CNR.TO :
* VERACYTE’S DECIPHER PROSTATE TEST IS NOW THE ONLY GENE
EXPRESSION TEST RECOMMENDED IN NCCN® PROSTATE CANCER GUIDELINES
Source text: ID:nBw4rfSc1a
Further company coverage: CNR.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Veracyte
See all newsU.S. STOCKS ON THE MOVE-Vor Biopharma, Fair Isaac Corp, Plug Power
U.S. STOCKS ON THE MOVE-Snowflake, Cboe, Oracle
US STOCKS ON THE MOVE-Veracyte, Staar Surgical, Corning
Veracyte gains on data supporting use of prostate cancer test to guide treatment decisions
Corrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina